GENE LOGIC INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6119
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6492109 Susceptibility mutation 6495delGC of BRCA2Sep 21, 98Dec 10, 02[L12O, C07H]
6130322 Coding sequences of the human BRCA1 geneMay 06, 98Oct 10, 00[C07H, A61K]
6083698 Cancer susceptibility mutations of BRCA1Dec 11, 97Jul 04, 00[C07H, C12Q, C12N]
6051379 Cancer susceptibility mutations of BRCA2Dec 02, 97Apr 18, 00[C07H, C12Q]
5756294 Susceptibility mutation for breast and ovarian cancerSep 25, 95May 26, 98[C07H, C12Q, C12P]
5750400 Coding sequences of the human BRCA1 geneFeb 12, 97May 12, 98[C07H, C12Q, C12P]
5654155 Consensus sequence of the human BRCA1 geneFeb 12, 96Aug 05, 97[C07H, C12Q, C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2008/0234,345 METHOD FOR REDUCING OR ALLEVIATING INFLAMMATION IN THE DIGESTIVE TRACTAbandonedSep 07, 07Sep 25, 08[A61K, A61P]
7428554 System and method for determining matching patterns within gene expression dataExpiredMay 20, 04Sep 23, 08[G06F]
2008/0132,474 BREAST CANCER SCREENING AND TREATMENT METHODSAbandonedNov 06, 07Jun 05, 08[A61K, G01N, A61P]
7321830 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profilesExpiredSep 24, 01Jan 22, 08[G06F]
2007/0020,618 Process to study changes in gene expression in T lymphocytesAbandonedApr 21, 06Jan 25, 07[C12Q]
2007/0015,146 Molecular nephrotoxicology modelingAbandonedNov 22, 02Jan 18, 07[C12Q, G01N, G06F]
2007/0015,148 Gene expression profiles in breast tissueAbandonedJan 25, 02Jan 18, 07[A61K, C12Q]
6974667 Gene expression profiles in liver cancerExpiredJun 14, 01Dec 13, 05[]
2005/0221,310 Methods for enhancing gene expression analysisAbandonedApr 11, 05Oct 06, 05[C12Q, C12P]
6951721 Method for determining the haplotype of a human BRCA1 geneExpiredAug 08, 01Oct 04, 05[C07H, C12Q, C12P]
2005/0170,375 Methods for enhancing gene expression analysisAbandonedSep 24, 04Aug 04, 05[C12Q, C12P]
2005/0147,969 Genes associated with mast cell activationAbandonedFeb 14, 05Jul 07, 05[C07H, C12Q, C07K]
2005/0084,896 Process to study changes in gene expression in granulocytic cellsAbandonedNov 10, 04Apr 21, 05[C12Q, C12N]
2005/0037,454 Gene associated with bone disordersAbandonedSep 30, 04Feb 17, 05[C07H, C12N]
2005/0014,142 Hybridization normalization methodsAbandonedSep 13, 04Jan 20, 05[C12Q]
2005/0015,206 Nucleic acid detection assay control genesAbandonedAug 27, 04Jan 20, 05[G01N]
6838256 Coding sequences of the human BRCA1 geneExpiredDec 13, 00Jan 04, 05[C07H, C12P, C12N]
2004/0234,995 System and method for storage and analysis of gene expression dataAbandonedMay 07, 04Nov 25, 04[C12Q, G01N, G06F]
2004/0181,049 Rna purification methodsAbandonedMay 07, 04Sep 16, 04[C07H]
2004/0115,686 Materials and methods to detect alternative splicing of mrnaAbandonedSep 15, 03Jun 17, 04[C12Q, C12M]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.